{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:43:55Z","timestamp":1792079035351,"version":"4.4.0"},"reference-count":243,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T00:00:00Z","timestamp":1788566400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.modpat.2026.101080","type":"journal-article","created":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T23:25:09Z","timestamp":1788823509000},"page":"101080","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["C-Cell Lesions and Medullary Thyroid Carcinoma: A Review"],"prefix":"10.1016","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-6391-6598","authenticated-orcid":false,"given":"Spencer C.","family":"Roark","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vania","family":"Nos\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole A.","family":"Cipriani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.modpat.2026.101080_bib1","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1210\/jcem-19-1-152","article-title":"Medullary (solid) carcinoma of the thyroid: a clinicopathologic entity","volume":"19","author":"Hazard","year":"1959","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.modpat.2026.101080_bib2","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1136\/jcp.19.2.114","article-title":"Histogenesis of medullary carcinoma of the thyroid","volume":"19","author":"Williams","year":"1966","journal-title":"J Clin Pathol"},{"issue":"1","key":"10.1016\/j.modpat.2026.101080_bib3","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/BF02889587","article-title":"Immunofluorescent localisation of calcitonin in medullary C-cell thyroid carcinoma, using antibody to the pure porcine hormone","volume":"2","author":"Bussolati","year":"1969","journal-title":"Virchows Arch B Cell Pathol"},{"issue":"5","key":"10.1016\/j.modpat.2026.101080_bib4","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1002\/1097-0142(197911)44:5<1769::AID-CNCR2820440534>3.0.CO;2-Z","article-title":"Medullary carcinoma of the thyroid with atypical patterns","volume":"44","author":"Bussolati","year":"1979","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.modpat.2026.101080_bib5","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2967\/jnmt.120.257105","article-title":"Thyroid follicular epithelial cell-derived cancer: new approaches and treatment strategies","volume":"49","author":"Bolin","year":"2021","journal-title":"J Nucl Med Technol"},{"issue":"5","key":"10.1016\/j.modpat.2026.101080_bib6","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1001\/jama.2023.26348","article-title":"Thyroid cancer: a review","volume":"331","author":"Boucai","year":"2024","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.modpat.2026.101080_bib7","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1073\/pnas.91.4.1579","article-title":"Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B","volume":"91","author":"Carlson","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"10.1016\/j.modpat.2026.101080_bib8","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1093\/hmg\/2.7.851","article-title":"Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC","volume":"2","author":"Donis-Keller","year":"1993","journal-title":"Hum Mol Genet"},{"issue":"2","key":"10.1016\/j.modpat.2026.101080_bib9","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/hmg\/3.2.237","article-title":"Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours","volume":"3","author":"Eng","year":"1994","journal-title":"Hum Mol Genet"},{"issue":"6461","key":"10.1016\/j.modpat.2026.101080_bib10","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/367375a0","article-title":"A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma","volume":"367","author":"Hofstra","year":"1994","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.modpat.2026.101080_bib11","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1046\/j.1365-2265.1996.681503.x","article-title":"Somatic mutations in the RET proto-oncogene in sporadic medullary thyroid carcinoma","volume":"44","author":"Marsh","year":"1996","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6428","key":"10.1016\/j.modpat.2026.101080_bib12","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/363458a0","article-title":"Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A","volume":"363","author":"Mulligan","year":"1993","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.modpat.2026.101080_bib13","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/ng0194-70","article-title":"Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC","volume":"6","author":"Mulligan","year":"1994","journal-title":"Nat Genet"},{"issue":"8","key":"10.1016\/j.modpat.2026.101080_bib14","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1210\/jc.2017-00317","article-title":"Medullary Thyroid Carcinoma in MEN2A: ATA moderate- or high-risk RET mutations do not predict disease aggressiveness","volume":"102","author":"Voss","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.modpat.2026.101080_bib15","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s12020-021-02607-2","article-title":"Timely diagnosis of multiple endocrine neoplasia 2B by identification of intestinal ganglioneuromatosis: a case series","volume":"72","author":"van den Broek","year":"2021","journal-title":"Endocrine"},{"issue":"6","key":"10.1016\/j.modpat.2026.101080_bib16","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvae048","article-title":"Next-generation sequencing in sporadic medullary thyroid cancer patients: mutation profile and disease aggressiveness","volume":"8","author":"Shirali","year":"2024","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.modpat.2026.101080_bib17","article-title":"Somatic genomic profiling reveals clinically relevant heterogeneity in RAS-mutant sporadic medullary thyroid carcinoma","volume":"44","author":"Ruggeri","year":"2026","journal-title":"J Clin Transl Endocrinol"},{"issue":"2","key":"10.1016\/j.modpat.2026.101080_bib18","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1089\/thy.2023.0482","article-title":"Tumor grade and molecular characteristics associated with survival in sporadic medullary thyroid carcinoma","volume":"34","author":"Censi","year":"2024","journal-title":"Thyroid"},{"issue":"4","key":"10.1016\/j.modpat.2026.101080_bib19","doi-asserted-by":"crossref","first-page":"485","DOI":"10.4103\/IJPM.IJPM_478_17","article-title":"C-cell hyperplasia in sporadic and familial medullary thyroid carcinoma","volume":"61","author":"Yadav","year":"2018","journal-title":"Indian J Pathol Microbiol"},{"issue":"4","key":"10.1016\/j.modpat.2026.101080_bib20","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1002\/(SICI)1097-0142(19960215)77:4<750::AID-CNCR22>3.0.CO;2-Z","article-title":"Physiologic versus neoplastic C-cell hyperplasia of the thyroid: separation of distinct histologic and biologic entities","volume":"77","author":"Perry","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.modpat.2026.101080_bib21","first-page":"53","article-title":"The C-cells: current concepts on normal histology and hyperplasia","volume":"45","author":"Borda","year":"1999","journal-title":"Romanian J Morphol Embryol"},{"issue":"8","key":"10.1016\/j.modpat.2026.101080_bib22","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1097\/01.MP.0000081727.75778.0C","article-title":"C-cell hyperplasia and medullary thyroid carcinoma: clinicopathological and genetic correlations in 66 consecutive patients","volume":"16","author":"Guy\u00e9tant","year":"2003","journal-title":"Mod Pathol"},{"issue":"10","key":"10.1016\/j.modpat.2026.101080_bib23","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1097\/00000478-200110000-00004","article-title":"Sporadic versus familial medullary thyroid microcarcinoma: a histopathologic study of 50 consecutive patients","volume":"25","author":"Kaserer","year":"2001","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.modpat.2026.101080_bib24","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1055\/s-0036-1579758","article-title":"Multiple endocrine neoplasia: a genetically diverse group of familial tumor syndromes","volume":"5","author":"Pacheco","year":"2016","journal-title":"J Pediatr Genet"},{"issue":"6","key":"10.1016\/j.modpat.2026.101080_bib25","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1093\/ejendo\/lvaf109","article-title":"Genetic origin of multifocal sporadic medullary thyroid cancer and C-cell hyperplasia","volume":"192","author":"de Almeida","year":"2025","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"10.1016\/j.modpat.2026.101080_bib26","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s12022-022-09708-2","article-title":"Overview of the 2022 WHO classification of neuroendocrine neoplasms","volume":"33","author":"Rindi","year":"2022","journal-title":"Endocr Pathol"},{"issue":"1","key":"10.1016\/j.modpat.2026.101080_bib27","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1200\/JCO.21.01329","article-title":"International Medullary Thyroid Carcinoma Grading System: a validated grading system for medullary thyroid carcinoma","volume":"40","author":"Xu","year":"2022","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.modpat.2026.101080_bib28","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1038\/s41379-020-0532-1","article-title":"Grading of medullary thyroid carcinoma on the basis of tumor necrosis and high mitotic rate is an independent predictor of poor outcome","volume":"33","author":"Alzumaili","year":"2020","journal-title":"Mod Pathol"},{"issue":"10","key":"10.1016\/j.modpat.2026.101080_bib29","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1097\/PAS.0000000000001505","article-title":"A proposed grading scheme for medullary thyroid carcinoma based on proliferative activity (Ki-67 and mitotic count) and coagulative necrosis","volume":"44","author":"Fuchs","year":"2020","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.modpat.2026.101080_bib30","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1089\/thy.2014.0335","article-title":"Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma","volume":"25","author":"Wells","year":"2015","journal-title":"Thyroid"},{"issue":"8","key":"10.1016\/j.modpat.2026.101080_bib31","doi-asserted-by":"crossref","first-page":"925","DOI":"10.6004\/jnccn.2022.0040","article-title":"Thyroid carcinoma, version 2.2022, NCCN clinical practice guidelines in oncology","volume":"20","author":"Haddad","year":"2022","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.modpat.2026.101080_bib32","doi-asserted-by":"crossref","DOI":"10.1177\/20420188251336091","article-title":"Systemic therapies for medullary thyroid carcinoma: state of the art","volume":"16","author":"Rom\u00e1n-Gonz\u00e1lez","year":"2025","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"166","key":"10.1016\/j.modpat.2026.101080_bib33","first-page":"557","article-title":"Contributions to the minute anatomy of the thyroid gland of the dog","author":"Baber","year":"1876","journal-title":"Philos Trans R Soc Lond"},{"issue":"2","key":"10.1016\/j.modpat.2026.101080_bib34","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1159\/000447333","article-title":"On the origin of cells and derivation of thyroid cancer: C cell story revisited","volume":"5","author":"Nilsson","year":"2016","journal-title":"Eur Thyroid J"},{"issue":"10","key":"10.1016\/j.modpat.2026.101080_bib35","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1634\/theoncologist.2010-0253","article-title":"The significance of h\u00fcrthle cells in thyroid disease","volume":"16","author":"Cannon","year":"2011","journal-title":"Oncologist"},{"key":"10.1016\/j.modpat.2026.101080_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-319-22542-5_1","article-title":"Thyroid C-cell biology and oncogenic transformation","volume":"204","author":"Cote","year":"2015","journal-title":"Recent Results Cancer Res"},{"key":"10.1016\/j.modpat.2026.101080_bib37","series-title":"Thyroid Hormone","article-title":"Paracrine regulation of thyroid-hormone synthesis by C cells","author":"Mara","year":"2012"},{"issue":"1","key":"10.1016\/j.modpat.2026.101080_bib38","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/1097-0142(19800101)45:1<98::AID-CNCR2820450117>3.0.CO;2-C","article-title":"Identification of carcinoembryonic antigen in the C-cell of the normal thyroid","volume":"45","author":"Kodama","year":"1980","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.modpat.2026.101080_bib39","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0092-8674(89)90970-7","article-title":"Carcinoembryonic antigen, a human tumor marker, functions as an intercellular adhesion molecule","volume":"57","author":"Benchimol","year":"1989","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.modpat.2026.101080_bib40","first-page":"213","article-title":"The C cells (parafollicular cells) of the thyroid gland and medullary thyroid carcinoma. A review","volume":"88","author":"Hazard","year":"1977","journal-title":"Am J Pathol"},{"issue":"20","key":"10.1016\/j.modpat.2026.101080_bib41","first-page":"3519","article-title":"Revising the embryonic origin of thyroid C cells in mice and humans","volume":"142","author":"Johansson","year":"2015","journal-title":"Development"},{"issue":"6","key":"10.1016\/j.modpat.2026.101080_bib42","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1210\/jcem-41-6-1076","article-title":"Distribution of calcitonin-containing cells in the normal neonatal human thyroid gland: a correlation of morphology with peptide content","volume":"41","author":"Wolfe","year":"1975","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.modpat.2026.101080_bib43","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000146717","article-title":"Electron-immunocytochemical localization of calcitonin and calcitonin-gene-related peptide in human C cells of the thyroid","volume":"135","author":"Kakudo","year":"2008","journal-title":"Acta Anat (Basel)"},{"key":"10.1016\/j.modpat.2026.101080_bib44","series-title":"StatPearls","article-title":"Calcitonin","author":"McLaughlin","year":"2026"},{"issue":"8","key":"10.1016\/j.modpat.2026.101080_bib45","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.1210\/jcem.86.8.7739","article-title":"Germline RET 634 mutation-positive MEN 2A-related C-cell hyperplasias have genetic features consistent with intraepithelial neoplasia","volume":"86","author":"Diaz-Cano","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.modpat.2026.101080_bib46","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s00292-015-0019-x","volume":"36","author":"Ting","year":"2015","journal-title":"Pathologe"},{"issue":"7","key":"10.1016\/j.modpat.2026.101080_bib47","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0046-8177(88)80262-4","article-title":"C-cell hyperplasia in thyroid tissue adjacent to follicular cell tumors","volume":"19","author":"Albores-Saavedra","year":"1988","journal-title":"Hum Pathol"},{"issue":"5","key":"10.1016\/j.modpat.2026.101080_bib48","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/0046-8177(94)90124-4","article-title":"C-cell hyperplasia associated with chronic lymphocytic thyroiditis: a retrospective quantitative study of 112 cases","volume":"25","author":"Guyetant","year":"1994","journal-title":"Hum Pathol"},{"issue":"4","key":"10.1016\/j.modpat.2026.101080_bib49","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1210\/jcem-37-4-550","article-title":"Demonstration by immunoperoxidase staining of hyperplasia of parafollicular cells in the thyroid gland in hyperparathyroidism","volume":"37","author":"LiVolsi","year":"1973","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.modpat.2026.101080_bib50","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1365-2265.1987.tb00845.x","article-title":"Immunohistochemical study of calcitonin gene-related peptide in human medullary carcinoma and C cell hyperplasia","volume":"27","author":"Williams","year":"1987","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"10.1016\/j.modpat.2026.101080_bib51","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1210\/jcem.82.1.3707","article-title":"C cell hyperplasia\/neoplasia","volume":"82","author":"LiVolsi","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.modpat.2026.101080_bib52","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1210\/jcem.82.1.3684","article-title":"Sex-related C cell hyperplasia in the normal human thyroid: a quantitative autopsy study","volume":"82","author":"Guy\u00e9tant","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.modpat.2026.101080_bib53","doi-asserted-by":"crossref","first-page":"144","DOI":"10.4103\/NJCA.NJCA_19_21","article-title":"The distribution of parafollicular cells (C cells) in adult cadaveric thyroid gland: an immunohistochemical study","volume":"10","author":"Hussain","year":"2021","journal-title":"Natl J Clin Anat"},{"issue":"6","key":"10.1016\/j.modpat.2026.101080_bib54","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1097\/00000478-199806000-00009","article-title":"C-cell hyperplasia and medullary thyroid carcinoma in patients routinely screened for serum calcitonin","volume":"22","author":"Kaserer","year":"1998","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.modpat.2026.101080_bib55","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1159\/000381605","article-title":"Incidental thyroid C-cell hyperplasia: clinical significance and implications in practice","volume":"38","author":"Sakorafas","year":"2015","journal-title":"Oncol Res Treat"},{"issue":"21","key":"10.1016\/j.modpat.2026.101080_bib56","doi-asserted-by":"crossref","first-page":"5554","DOI":"10.3390\/cancers13215554","article-title":"Active surveillance in RET gene carriers belonging to families with multiple endocrine neoplasia","volume":"13","author":"Prete","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.modpat.2026.101080_bib57","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0300-595X(81)80027-8","article-title":"Familial medullary thyroid carcinoma and C cell hyperplasia","volume":"10","author":"Wolfe","year":"1981","journal-title":"Clin Endocrinol Metab"},{"key":"10.1016\/j.modpat.2026.101080_bib58","first-page":"105","article-title":"Multiple endocrine neoplasia, type 2b","volume":"8","author":"Carney","year":"1978","journal-title":"Pathobiol Annu"},{"issue":"12","key":"10.1016\/j.modpat.2026.101080_bib59","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/0046-8177(95)90294-5","article-title":"Immunostains for collagen type IV discriminate between C-cell hyperplasia and microscopic medullary carcinoma in multiple endocrine neoplasia, type 2a","volume":"26","author":"Mcdermott","year":"1995","journal-title":"Hum Pathol"},{"issue":"Suppl 1","key":"10.1016\/j.modpat.2026.101080_bib60","first-page":"60","article-title":"C-cells and their associated lesions and conditions: a pathologists perspective","volume":"31","author":"Baloch","year":"2015","journal-title":"Turk Patoloji Derg"},{"issue":"5","key":"10.1016\/j.modpat.2026.101080_bib61","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.suc.2009.06.021","article-title":"Sporadic and familial medullary thyroid carcinoma: state of the Art","volume":"89","author":"Moo-Young","year":"2009","journal-title":"Surg Clin North Am"},{"issue":"3","key":"10.1016\/j.modpat.2026.101080_bib62","first-page":"142","article-title":"Genetic and epigenetic of medullary thyroid cancer","volume":"22","author":"Khatami","year":"2018","journal-title":"Iran Biomed J"},{"issue":"Suppl 2","key":"10.1016\/j.modpat.2026.101080_bib63","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1038\/modpathol.2010.147","article-title":"Familial thyroid cancer: a review","volume":"24","author":"Nos\u00e9","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1016\/j.modpat.2026.101080_bib64","article-title":"Critically evaluated key points on hereditary medullary thyroid carcinoma","volume":"15","author":"Zhang","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"10.1016\/j.modpat.2026.101080_bib65","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/0092-8674(85)90115-1","article-title":"Activation of a novel human transforming gene, ret, by DNA rearrangement","volume":"42","author":"Takahashi","year":"1985","journal-title":"Cell"},{"issue":"6461","key":"10.1016\/j.modpat.2026.101080_bib66","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/367380a0","article-title":"Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret","volume":"367","author":"Schuchardt","year":"1994","journal-title":"Nature"},{"issue":"6586","key":"10.1016\/j.modpat.2026.101080_bib67","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/382070a0","article-title":"Renal agenesis and the absence of enteric neurons in mice lacking GDNF","volume":"382","author":"S\u00e1nchez","year":"1996","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.modpat.2026.101080_bib68","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0896-6273(00)80514-0","article-title":"GFR\u03b11 is an essential receptor component for GDNF in the developing nervous system and kidney","volume":"21","author":"Cacalano","year":"1998","journal-title":"Neuron"},{"issue":"18","key":"10.1016\/j.modpat.2026.101080_bib69","doi-asserted-by":"crossref","first-page":"8026","DOI":"10.1128\/MCB.24.18.8026-8036.2004","article-title":"A targeting mutation of tyrosine 1062 in ret causes a marked decrease of enteric neurons and renal hypoplasia","volume":"24","author":"Jijiwa","year":"2004","journal-title":"Mol Cell Biol"},{"issue":"12","key":"10.1016\/j.modpat.2026.101080_bib70","first-page":"1519","article-title":"Human ret proto-oncogene mapped to chromosome 10q11.2","volume":"4","author":"Ishizaka","year":"1989","journal-title":"Oncogene"},{"issue":"9","key":"10.1016\/j.modpat.2026.101080_bib71","first-page":"1737","article-title":"The physical map of the human RET proto-oncogene","volume":"11","author":"Pasini","year":"1995","journal-title":"Oncogene"},{"issue":"6130","key":"10.1016\/j.modpat.2026.101080_bib72","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/328528a0","article-title":"Assignment of multiple endocrine neoplasia type 2A to chromosome 10 by linkage","volume":"328","author":"Simpson","year":"1987","journal-title":"Nature"},{"issue":"6130","key":"10.1016\/j.modpat.2026.101080_bib73","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/328527a0","article-title":"A linked genetic marker for multiple endocrine neoplasia type 2A on chromosome 10","volume":"328","author":"Mathew","year":"1987","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.modpat.2026.101080_bib74","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3747\/co.26.5553","article-title":"A primer on the genetics of medullary thyroid cancer","volume":"26","author":"Larouche","year":"2019","journal-title":"Curr Oncol"},{"issue":"8","key":"10.1016\/j.modpat.2026.101080_bib75","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1210\/jc.2013-1204","article-title":"Multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma: an update","volume":"98","author":"Wells","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.modpat.2026.101080_bib76","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.semcancer.2021.03.035","article-title":"Multiple endocrine neoplasia type 2: a review","volume":"79","author":"Mathiesen","year":"2022","journal-title":"Semin Cancer Biol"},{"issue":"7","key":"10.1016\/j.modpat.2026.101080_bib77","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1308\/rcsann.2020.0056","article-title":"Medullary thyroid cancer: epidemiological pattern and factors contributing to recurrence and metastasis","volume":"102","author":"Hamdy","year":"2020","journal-title":"Ann R Coll Surg Engl"},{"issue":"10","key":"10.1016\/j.modpat.2026.101080_bib78","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1634\/theoncologist.2013-0053","article-title":"Current understanding and management of medullary thyroid cancer","volume":"18","author":"Roy","year":"2013","journal-title":"Oncologist"},{"issue":"1","key":"10.1016\/j.modpat.2026.101080_bib79","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3892\/ol.2010.223","article-title":"Medullary thyroid carcinoma: The third most common thyroid cancer reviewed","volume":"2","author":"Stamatakos","year":"2011","journal-title":"Oncol Lett"},{"key":"10.1016\/j.modpat.2026.101080_bib80","doi-asserted-by":"crossref","DOI":"10.1177\/20406223221079246","article-title":"Multiple endocrine neoplasia 2: an overview","volume":"13","author":"Saravana-Bawan","year":"2022","journal-title":"Ther Adv Chronic Dis"},{"key":"10.1016\/j.modpat.2026.101080_bib81","series-title":"StatPearls","article-title":"Multiple Endocrine Neoplasias Type 2","author":"Lath","year":"2026"},{"issue":"8","key":"10.1016\/j.modpat.2026.101080_bib82","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1210\/js.2018-00178","article-title":"Update on multiple endocrine neoplasia type 2: focus on medullary thyroid carcinoma","volume":"2","author":"Raue","year":"2018","journal-title":"J Endocr Soc"},{"issue":"11","key":"10.1016\/j.modpat.2026.101080_bib83","doi-asserted-by":"crossref","first-page":"E1813","DOI":"10.1210\/jc.2013-1653","article-title":"The characterization of pheochromocytoma and its impact on overall survival in multiple endocrine neoplasia type 2","volume":"98","author":"Thosani","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.modpat.2026.101080_bib84","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.neo.2014.09.002","article-title":"Adrenal medullary hyperplasia is a precursor lesion for pheochromocytoma in MEN2 syndrome","volume":"16","author":"Korpershoek","year":"2014","journal-title":"Neoplasia"},{"key":"10.1016\/j.modpat.2026.101080_bib85","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/978-3-319-22542-5_8","article-title":"Primary Hyperparathyroidism in MEN2 syndromes","volume":"204","author":"Alevizaki","year":"2015","journal-title":"Recent results in cancer research. Fortschritte Krebsforsch Progres dans Rech sur Cancer"},{"issue":"4","key":"10.1016\/j.modpat.2026.101080_bib86","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s10689-016-9892-6","article-title":"MEN 2A-related cutaneous lichen amyloidosis: report of three kindred and systematic literature review of clinical, biochemical, and molecular characteristics","volume":"15","author":"Scapineli","year":"2016","journal-title":"Fam Cancer"},{"issue":"8","key":"10.1016\/j.modpat.2026.101080_bib87","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s00383-014-3538-2","article-title":"The association between Hirschsprung\u2019s disease and multiple endocrine neoplasia type 2a: a systematic review","volume":"30","author":"Coyle","year":"2014","journal-title":"Pediatr Surg Int"},{"issue":"6","key":"10.1016\/j.modpat.2026.101080_bib88","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1111\/cen.12686","article-title":"Twenty years of lesson learning: how does the RET genetic screening test impact the clinical management of medullary thyroid cancer?","volume":"82","author":"Romei","year":"2015","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"10.1016\/j.modpat.2026.101080_bib89","doi-asserted-by":"crossref","first-page":"T29","DOI":"10.1530\/ERC-17-0209","article-title":"A comprehensive review on MEN2B","volume":"25","author":"Castinetti","year":"2018","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.modpat.2026.101080_bib90","doi-asserted-by":"crossref","unstructured":"Taccaliti A, Silvetti F, Palmonella G Boscaro M. Genetic alterations in medullary thyroid cancer: diagnostic and prognostic markers. Curr Genomics. 12(8):618-625. doi:10.2174\/138920211798120835.","DOI":"10.2174\/138920211798120835"},{"issue":"4","key":"10.1016\/j.modpat.2026.101080_bib91","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1007\/s12328-024-01979-y","article-title":"Multiple endocrine neoplasia type 2B diagnosed after small intestinal volvulus with progressive megacolon in an adolescent","volume":"17","author":"Sakai","year":"2024","journal-title":"Clin J Gastroenterol"},{"issue":"9","key":"10.1016\/j.modpat.2026.101080_bib92","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/GIM.0b013e318216cc6d","article-title":"Multiple endocrine neoplasia type 2: an overview","volume":"13","author":"Moline","year":"2011","journal-title":"Genet Med"},{"issue":"2","key":"10.1016\/j.modpat.2026.101080_bib93","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1089\/thy.2010.0328","article-title":"Multiple endocrine neoplasia type 2B with a RET proto-oncogene A883F mutation displays a more indolent form of medullary thyroid carcinoma compared with a RET M918T mutation","volume":"21","author":"Jasim","year":"2011","journal-title":"Thyroid"},{"issue":"3","key":"10.1016\/j.modpat.2026.101080_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2024.109549","article-title":"Dissection of RET p.M918T-driven progression of hereditary vs. sporadic medullary thyroid cancer","volume":"51","author":"Machens","year":"2025","journal-title":"Eur J Surg Oncol"},{"issue":"10","key":"10.1016\/j.modpat.2026.101080_bib95","first-page":"3088","article-title":"Mutations of codon 918 in the RET proto-oncogene correlate to poor prognosis in sporadic medullary thyroid carcinomas","volume":"80","author":"Zedenius","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"10.1016\/j.modpat.2026.101080_bib96","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1089\/thy.2012.0236","article-title":"Prevalence and clinical spectrum of nonsecretory medullary thyroid carcinoma in a series of 839 patients with sporadic medullary thyroid carcinoma","volume":"23","author":"Frank-Raue","year":"2013","journal-title":"Thyroid"},{"issue":"Suppl 15","key":"10.1016\/j.modpat.2026.101080_bib97","article-title":"RAS-mutated sporadic medullary thyroid cancer: a single-center experience","volume":"38","author":"Brown","year":"2020","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.modpat.2026.101080_bib98","doi-asserted-by":"crossref","first-page":"E863","DOI":"10.1210\/jc.2010-1921","article-title":"High prevalence of RAS mutations in RET-negative sporadic medullary thyroid carcinomas","volume":"96","author":"Moura","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.modpat.2026.101080_bib99","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.3390\/cancers14081951","article-title":"Medullary thyroid carcinoma mutational spectrum update and signaling-type inference by transcriptional profiles: literature meta-analysis and study of tumor samples","volume":"14","author":"Minna","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"10","key":"10.1016\/j.modpat.2026.101080_bib100","doi-asserted-by":"crossref","first-page":"E2031","DOI":"10.1210\/jc.2012-2092","article-title":"Somatic RAS Mutations occur in a large proportion of sporadic RET-negative medullary thyroid carcinomas and extend to a previously unidentified exon","volume":"97","author":"Boichard","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.modpat.2026.101080_bib101","doi-asserted-by":"crossref","first-page":"121","DOI":"10.5603\/EP.2015.0018","article-title":"The prevalence of somatic RAS mutations in medullary thyroid cancer \u2014 a Polish population study","volume":"66","author":"Oczko-Wojciechowska","year":"2015","journal-title":"Endokrynol Pol"},{"issue":"2","key":"10.1016\/j.modpat.2026.101080_bib102","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/cen.12563","article-title":"Detection rate of FNA cytology in medullary thyroid carcinoma: a meta-analysis","volume":"82","author":"Trimboli","year":"2015","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"10.1016\/j.modpat.2026.101080_bib103","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/(SICI)1097-0339(200006)22:6<351::AID-DC5>3.0.CO;2-T","article-title":"Cytologic diagnosis of medullary carcinoma of the thyroid gland","volume":"22","author":"Papaparaskeva","year":"2000","journal-title":"Diagn Cytopathol"},{"issue":"1","key":"10.1016\/j.modpat.2026.101080_bib104","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/dc.24586","article-title":"Cytologic diagnosis of medullary thyroid carcinoma in the Asia-Pacific region","volume":"49","author":"Liu","year":"2021","journal-title":"Diagn Cytopathol"},{"issue":"8","key":"10.1016\/j.modpat.2026.101080_bib105","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.3390\/diagnostics11081396","article-title":"Constitutive cytomorphologic features of medullary thyroid carcinoma using different staining methods","volume":"11","author":"Liu","year":"2021","journal-title":"Diagnostics (Basel)"},{"issue":"5","key":"10.1016\/j.modpat.2026.101080_bib106","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/(SICI)1097-0142(19981025)84:5<295::AID-CNCR5>3.0.CO;2-J","article-title":"Medullary carcinoma of the thyroid: accuracy of diagnosis of fine-needle aspiration cytology","volume":"84","author":"Forrest","year":"1998","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.modpat.2026.101080_bib107","doi-asserted-by":"crossref","DOI":"10.1002\/cncy.70023","article-title":"The diagnostic challenges of medullary thyroid carcinoma: a practical guide for cytopathologists","volume":"133","author":"Pusztaszeri","year":"2025","journal-title":"Cancer Cytopathol"},{"issue":"4","key":"10.1016\/j.modpat.2026.101080_bib108","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/cncy.22778","article-title":"Grading medullary thyroid carcinoma on fine-needle aspiration cytology specimens with the International Medullary Thyroid Carcinoma Grading System: a cytologic-histologic correlation","volume":"132","author":"Viswanathan","year":"2024","journal-title":"Cancer Cytopathol"},{"issue":"2","key":"10.1016\/j.modpat.2026.101080_bib109","doi-asserted-by":"crossref","first-page":"66","DOI":"10.4103\/0970-9371.70745","article-title":"FNAC diagnosis of medullary carcinoma thyroid: A report of three cases with review of literature","volume":"27","author":"Mehdi","year":"2010","journal-title":"J Cytol"},{"issue":"1","key":"10.1016\/j.modpat.2026.101080_bib110","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/(SICI)1097-0142(19970225)81:1<40::AID-CNCR9>3.0.CO;2-K","article-title":"A spectrum of cytomorphologic variations in medullary thyroid carcinoma. Fine-needle aspiration findings in 19 cases","volume":"81","author":"Green","year":"1997","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.modpat.2026.101080_bib111","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1002\/dc.23790","article-title":"Oncocytic variant of medullary thyroid carcinoma: a rare tumor with numerous diagnostic mimics by fine-needle aspiration","volume":"45","author":"Sams","year":"2017","journal-title":"Diagn Cytopathol"},{"issue":"9","key":"10.1016\/j.modpat.2026.101080_bib112","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/dc.24220","article-title":"Medullary carcinoma of the thyroid mimicking Hurthle cell neoplasm on cytology: a diagnostic dilemma","volume":"47","author":"Agarwal","year":"2019","journal-title":"Diagn Cytopathol"},{"issue":"8","key":"10.1016\/j.modpat.2026.101080_bib113","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.5858\/2008-132-1241-TTHOCA","article-title":"The thyroid H\u00fcrthle (oncocytic) cell and its associated pathologic conditions: a surgical pathology and cytopathology review","volume":"132","author":"Montone","year":"2008","journal-title":"Arch Pathol Lab Med"},{"issue":"2","key":"10.1016\/j.modpat.2026.101080_bib114","doi-asserted-by":"crossref","first-page":"60","DOI":"10.4103\/0973-0354.96057","article-title":"Spindle cell variant of medullary carcinoma of thyroid with nodal metastasis: cytodiagnosis and diagnostic dilemma","volume":"9","author":"Mondal","year":"2012","journal-title":"Thyroid Res Pract"},{"issue":"1","key":"10.1016\/j.modpat.2026.101080_bib115","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/dc.23375","article-title":"Use of fine-needle aspirate calcitonin to detect medullary thyroid carcinoma: a systematic review","volume":"44","author":"Trimboli","year":"2016","journal-title":"Diagn Cytopathol"},{"issue":"1","key":"10.1016\/j.modpat.2026.101080_bib116","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1111\/cen.12234","article-title":"Calcitonin measurement in aspiration needle washout fluids has higher sensitivity than cytology in detecting medullary thyroid cancer: a retrospective multicentre study","volume":"80","author":"Trimboli","year":"2014","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"10.1016\/j.modpat.2026.101080_bib117","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/BF03345717","article-title":"Calcitonin assay in wash-out fluid after fine-needle aspiration biopsy in patients with a thyroid nodule and borderline value of the hormone","volume":"32","author":"Massaro","year":"2009","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"10.1016\/j.modpat.2026.101080_bib118","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s12022-013-9287-2","article-title":"Medullary thyroid carcinoma: a 25-year perspective","volume":"25","author":"Matias-Guiu","year":"2014","journal-title":"Endocr Pathol"},{"issue":"1","key":"10.1016\/j.modpat.2026.101080_bib119","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4103\/0019-509X.15096","article-title":"A study of histopathological features of medullary carcinoma of the thyroid: Cases from a single institute in India","volume":"42","author":"Desai","year":"2005","journal-title":"Indian J Cancer"},{"issue":"2","key":"10.1016\/j.modpat.2026.101080_bib120","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1385\/EP:13:2:167","article-title":"Encapsulated cystic papillary variant of medullary carcinoma of thyroid gland","volume":"13","author":"Ozkara","year":"2002","journal-title":"Endocr Pathol"},{"issue":"1","key":"10.1016\/j.modpat.2026.101080_bib121","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3390\/biomedicines11010116","article-title":"Clinicopathological profile of medullary thyroid carcinoma\u2014could we predict aggressive behavior?","volume":"11","author":"Giusca","year":"2023","journal-title":"Biomedicines"},{"issue":"2","key":"10.1016\/j.modpat.2026.101080_bib122","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1021\/acs.molpharmaceut.1c00680","article-title":"Targeting Amyloids with [18F]AV-45 for medullary thyroid carcinoma positron emission tomography\/computed tomography imaging: a pilot clinical study","volume":"19","author":"Li","year":"2022","journal-title":"Mol Pharm"},{"issue":"12","key":"10.1016\/j.modpat.2026.101080_bib123","doi-asserted-by":"crossref","first-page":"5465","DOI":"10.1210\/en.2004-0780","article-title":"Unraveling the amyloid associated with human medullary thyroid carcinoma","volume":"145","author":"Khurana","year":"2004","journal-title":"Endocrinology"},{"issue":"9","key":"10.1016\/j.modpat.2026.101080_bib124","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1007\/s40618-020-01456-6","article-title":"Correlation of molecular data with histopathological and clinical features in a series of 66 patients with medullary thyroid carcinoma","volume":"44","author":"Moura","year":"2021","journal-title":"J Endocrinol Invest"},{"issue":"4","key":"10.1016\/j.modpat.2026.101080_bib125","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.eprac.2024.01.001","article-title":"Survival outcomes of medullary thyroid cancer with and without amyloid deposition","volume":"30","author":"Toraih","year":"2024","journal-title":"Endocr Pract"},{"issue":"6","key":"10.1016\/j.modpat.2026.101080_bib126","doi-asserted-by":"crossref","first-page":"W867","DOI":"10.2214\/AJR.12.10370","article-title":"Current update on medullary thyroid carcinoma","volume":"201","author":"Ganeshan","year":"2013","journal-title":"Am J Roentgenol"},{"issue":"2","key":"10.1016\/j.modpat.2026.101080_bib127","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s12022-019-9567-6","article-title":"Revisiting the significance of prominent C cells in the thyroid","volume":"30","author":"Fuchs","year":"2019","journal-title":"Endocr Pathol"},{"issue":"9","key":"10.1016\/j.modpat.2026.101080_bib128","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/dc.23020","article-title":"Diagnosis of pseudopapillary variant of medullary thyroid carcinoma by fine-needle aspiration cytology","volume":"42","author":"Kawanishi","year":"2014","journal-title":"Diagn Cytopathol"},{"issue":"1","key":"10.1016\/j.modpat.2026.101080_bib129","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s12022-014-9332-9","article-title":"Images in endocrine pathology: papillary variant of medullary thyroid carcinoma with cystic change","volume":"26","author":"Hyrcza","year":"2015","journal-title":"Endocr Pathol"},{"issue":"1","key":"10.1016\/j.modpat.2026.101080_bib130","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0344-0338(88)80198-5","article-title":"Follicular and papillary variants of medullary carcinoma of the thyroid","volume":"184","author":"Sambade","year":"1988","journal-title":"Pathol Res Pract"},{"issue":"1","key":"10.1016\/j.modpat.2026.101080_bib131","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1385\/EP:13:1:75","article-title":"Medullary thyroid carcinoma, follicular variant","volume":"13","author":"Cakir","year":"2002","journal-title":"Endocr Pathol"},{"issue":"1","key":"10.1016\/j.modpat.2026.101080_bib132","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s13000-021-01152-w","article-title":"Spindle cell variant of medullary thyroid carcinoma: a clinicopathologic study of four cases","volume":"16","author":"Wang","year":"2021","journal-title":"Diagn Pathol"},{"issue":"1","key":"10.1016\/j.modpat.2026.101080_bib133","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/PAP.0000000000000004","article-title":"Update on the cytologic and molecular features of medullary thyroid carcinoma","volume":"21","author":"Pusztaszeri","year":"2014","journal-title":"Adv Anat Pathol"},{"issue":"1","key":"10.1016\/j.modpat.2026.101080_bib134","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0344-0338(00)80022-9","article-title":"Sustentacular cells in sporadic paraganglioma-like medullary thyroid carcinoma: report of a case with diagnostic and histogenetic considerations","volume":"196","author":"Magro","year":"2000","journal-title":"Pathol Res Pract"},{"issue":"12","key":"10.1016\/j.modpat.2026.101080_bib135","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1089\/thy.2005.15.1363","article-title":"Paraganglioma-like medullary thyroid carcinoma: a rare entity","volume":"15","author":"Bockhorn","year":"2005","journal-title":"Thyroid"},{"issue":"6","key":"10.1016\/j.modpat.2026.101080_bib136","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/dc.24403","article-title":"Paraganglioma-like medullary thyroid carcinoma: a case report and literature review","volume":"48","author":"Hou","year":"2020","journal-title":"Diagn Cytopathol"},{"issue":"4","key":"10.1016\/j.modpat.2026.101080_bib137","doi-asserted-by":"crossref","first-page":"562","DOI":"10.4103\/IJPM.IJPM_187_17","article-title":"Small cell medullary thyroid carcinoma: A diagnostic dilemma","volume":"60","author":"Verma","year":"2017","journal-title":"Indian J Pathol Microbiol"},{"issue":"1","key":"10.1016\/j.modpat.2026.101080_bib138","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjoto.2019.102312","article-title":"The role of molecular testing in the diagnosis of medullary thyroid cancer: a case report of oncocytic medullary thyroid carcinoma and review of the literature","volume":"41","author":"Spaulding","year":"2020","journal-title":"Am J Otolaryngol"},{"issue":"1","key":"10.1016\/j.modpat.2026.101080_bib139","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s13000-018-0764-2","article-title":"Pathological characteristics and genetic features of melanin-producing medullary thyroid carcinoma","volume":"13","author":"Wang","year":"2018","journal-title":"Diagn Pathol"},{"issue":"6","key":"10.1016\/j.modpat.2026.101080_bib140","doi-asserted-by":"crossref","first-page":"569","DOI":"10.3109\/01913129709016373","article-title":"Amphicrine medullary carcinoma of the thyroid with luminal differentiation: report of an immunohistochemical and ultrastructural study","volume":"21","author":"Dominguez-Malagon","year":"1997","journal-title":"Ultrastruct Pathol"},{"issue":"10","key":"10.1016\/j.modpat.2026.101080_bib141","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1245\/s10434-009-0595-1","article-title":"Micromedullary thyroid cancer: how micro is truly micro?","volume":"16","author":"Pillarisetty","year":"2009","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.modpat.2026.101080_bib142","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1210\/jc.2011-2534","article-title":"Biological relevance of medullary thyroid microcarcinoma","volume":"97","author":"Machens","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.modpat.2026.101080_bib143","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1210\/clinem\/dgad173","article-title":"Natural history and predictive factors of outcome in medullary thyroid microcarcinoma","volume":"108","author":"Kesby","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.modpat.2026.101080_bib144","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/PAP.0b013e3181e4ab3e","article-title":"Mixed medullary-follicular-derived carcinomas of the thyroid gland","volume":"17","author":"Sadow","year":"2010","journal-title":"Adv Anat Pathol"},{"issue":"2","key":"10.1016\/j.modpat.2026.101080_bib145","first-page":"109","article-title":"Thyroid carcinomas with mixed follicular and C-cell differentiation patterns","volume":"17","author":"Papotti","year":"2000","journal-title":"Semin Diagn Pathol"},{"issue":"11","key":"10.1016\/j.modpat.2026.101080_bib146","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/0046-8177(90)90152-U","article-title":"Mixed medullary-papillary carcinoma of the thyroid: a previously unrecognized variant of thyroid carcinoma","volume":"21","author":"Albores-Saavedra","year":"1990","journal-title":"Hum Pathol"},{"issue":"4","key":"10.1016\/j.modpat.2026.101080_bib147","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/BF00190568","article-title":"Coexistence of papillary and medullary carcinoma of the thyroid gland\u2014mixed or collision tumour? Clinicopathological analysis of three cases","volume":"424","author":"Lax","year":"1994","journal-title":"Virchows Arch Int J Pathol"},{"issue":"5","key":"10.1016\/j.modpat.2026.101080_bib148","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/S0002-9440(10)65465-X","article-title":"Mixed medullary-follicular thyroid carcinoma. Molecular evidence for a dual origin of tumor components","volume":"155","author":"Volante","year":"1999","journal-title":"Am J Pathol"},{"issue":"4","key":"10.1016\/j.modpat.2026.101080_bib149","doi-asserted-by":"crossref","first-page":"598","DOI":"10.4103\/0377-4929.142684","article-title":"Mixed medullary-papillary carcinoma of the thyroid: Report of two cases and review of the literature","volume":"57","author":"Gurkan","year":"2014","journal-title":"Indian J Pathol Microbiol"},{"issue":"3","key":"10.1016\/j.modpat.2026.101080_bib150","doi-asserted-by":"crossref","first-page":"E125","DOI":"10.1002\/dc.24615","article-title":"Cytologic features of a case of mixed medullary and follicular cell-derived thyroid carcinoma with review of the literature","volume":"49","author":"Chambers","year":"2021","journal-title":"Diagn Cytopathol"},{"issue":"1","key":"10.1016\/j.modpat.2026.101080_bib151","article-title":"Medullary thyroid carcinoma and papillary thyroid carcinoma in the same patient as a collision tumor","volume":"2019","author":"Dikbas","year":"2019","journal-title":"Case Rep Endocrinol"},{"issue":"3","key":"10.1016\/j.modpat.2026.101080_bib152","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1089\/thy.1991.1.249","article-title":"Study of calcitonin and thyroglobulin gene expression in human mixed follicular and medullary thyroid carcinoma","volume":"1","author":"Noel","year":"1991","journal-title":"Thyroid"},{"issue":"6","key":"10.1016\/j.modpat.2026.101080_bib153","first-page":"300","article-title":"Mixed medullary-follicular thyroid carcinoma. Report of a case and review of the literature","volume":"61","author":"Kostoglou-Athanassiou","year":"2004","journal-title":"Horm Res"},{"issue":"3","key":"10.1016\/j.modpat.2026.101080_bib154","doi-asserted-by":"crossref","first-page":"e63","DOI":"10.1308\/rcsann.2019.0153","article-title":"Calcitonin-negative medullary thyroid carcinoma: the \u201ctriple-negative\u201d phenotype","volume":"102","author":"Murphy","year":"2020","journal-title":"Ann R Coll Surg Engl"},{"issue":"4","key":"10.1016\/j.modpat.2026.101080_bib155","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3390\/pathophysiology32040056","article-title":"Medullary thyroid carcinoma without calcitonin: a case linking ultimobranchial bodies to tumor evolution","volume":"32","author":"Prisneac","year":"2025","journal-title":"Pathophysiology"},{"issue":"Suppl 1","key":"10.1016\/j.modpat.2026.101080_bib156","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12902-019-0367-2","article-title":"Calcitonin-negative medullary thyroid carcinoma: a challenging diagnosis or a medical dilemma?","volume":"19","author":"Gambardella","year":"2019","journal-title":"BMC Endocr Disord"},{"issue":"10","key":"10.1016\/j.modpat.2026.101080_bib157","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.21037\/gs-24-292","article-title":"Diagnostic challenges in calcitonin-negative medullary thyroid carcinoma: a systematic review of 101 cases","volume":"13","author":"Abaalkhail","year":"2024","journal-title":"Gland Surg"},{"issue":"3","key":"10.1016\/j.modpat.2026.101080_bib158","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/S0046-8177(00)80255-5","article-title":"Expression of thyroid transcription factor-1 (TTF-1) in human C cells and medullary thyroid carcinomas","volume":"31","author":"Katoh","year":"2000","journal-title":"Hum Pathol"},{"issue":"3","key":"10.1016\/j.modpat.2026.101080_bib159","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/00129039-200009000-00004","article-title":"Thyroid transcription factor-1, thyroglobulin, cytokeratin 7, and cytokeratin 20 in thyroid neoplasms","volume":"8","author":"Bejarano","year":"2000","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"2","key":"10.1016\/j.modpat.2026.101080_bib160","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/modpathol.3801002","article-title":"Diagnostic utility of thyroid transcription factors Pax8 and TTF-2 (FoxE1) in thyroid epithelial neoplasms","volume":"21","author":"Nonaka","year":"2008","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.modpat.2026.101080_bib161","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s12022-019-09603-3","article-title":"Do you know the details of your PAX8 Antibody? Monoclonal PAX8 (MRQ-50) is not expressed in a series of 45 medullary thyroid carcinomas","volume":"31","author":"Gucer","year":"2020","journal-title":"Endocr Pathol"},{"issue":"5","key":"10.1016\/j.modpat.2026.101080_bib162","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1440-1827.2006.01959.x","article-title":"Immunohistochemical analysis of thyroid-specific transcription factors in thyroid tumors","volume":"56","author":"Zhang","year":"2006","journal-title":"Pathol Int"},{"issue":"6","key":"10.1016\/j.modpat.2026.101080_bib163","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/modpathol.3800105","article-title":"Thyroid transcription factor-1, but not p53, is helpful in distinguishing moderately differentiated neuroendocrine carcinoma of the larynx from medullary carcinoma of the thyroid","volume":"17","author":"Hirsch","year":"2004","journal-title":"Mod Pathol"},{"issue":"3","key":"10.1016\/j.modpat.2026.101080_bib164","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1530\/eje.0.1400187","article-title":"Gastroenteropancreatic neuroendocrine tumor metastases to the thyroid gland: differential diagnosis with medullary thyroid carcinoma","volume":"140","author":"Leboulleux","year":"1999","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"10.1016\/j.modpat.2026.101080_bib165","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1097\/00000478-199707000-00003","article-title":"Metastatic neuroendocrine tumors to the thyroid gland mimicking medullary carcinoma: a pathologic and immunohistochemical study of six cases","volume":"21","author":"Matias-Guiu","year":"1997","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"10.1016\/j.modpat.2026.101080_bib166","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s12022-021-09672-3","article-title":"Neuroendocrine tumors of the thyroid and their mimics","volume":"32","author":"LiVolsi","year":"2021","journal-title":"Endocr Pathol"},{"issue":"3","key":"10.1016\/j.modpat.2026.101080_bib167","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00428-019-02708-4","article-title":"PAX8 expression in anaplastic thyroid carcinoma is less than those reported in early studies: a multi-institutional study of 182 cases using the monoclonal antibody MRQ-50","volume":"476","author":"Lai","year":"2020","journal-title":"Virchows Arch"},{"issue":"8","key":"10.1016\/j.modpat.2026.101080_bib168","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1002\/(SICI)1097-0142(19960415)77:8<1556::AID-CNCR20>3.0.CO;2-Y","article-title":"Multivariate analysis of patients with medullary thyroid carcinoma. Prognostic significance and impact on treatment of clinical and pathologic variables","volume":"77","author":"Dottorini","year":"1996","journal-title":"Cancer"},{"issue":"9","key":"10.1016\/j.modpat.2026.101080_bib169","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1245\/s10434-010-1021-4","article-title":"Prognostic value of histologic and immunohistochemical characteristics for predicting the recurrence of medullary thyroid carcinoma","volume":"17","author":"R\u00edos","year":"2010","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"10.1016\/j.modpat.2026.101080_bib170","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1002\/cncr.22244","article-title":"Prognosis of medullary thyroid carcinoma: demographic, clinical, and pathologic predictors of survival in 1252 cases","volume":"107","author":"Roman","year":"2006","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.modpat.2026.101080_bib171","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/BF00210956","article-title":"Prognostic factors in medullary thyroid carcinoma: evaluation of 741 patients from the German medullary thyroid carcinoma register","volume":"71","author":"Raue","year":"1993","journal-title":"Clin Investig"},{"issue":"4","key":"10.1016\/j.modpat.2026.101080_bib172","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1002\/1097-0142(19880215)61:4<806::AID-CNCR2820610428>3.0.CO;2-G","article-title":"Prognostic factors in medullary thyroid carcinomas. Survival in relation to age, sex, stage, histology, immunocytochemistry, and DNA content","volume":"61","author":"Schr\u00f6der","year":"1988","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.modpat.2026.101080_bib173","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.amjsurg.2020.09.025","article-title":"Association between age and disease-specific mortality in medullary thyroid cancer","volume":"221","author":"Sahli","year":"2021","journal-title":"Am J Surg"},{"issue":"5","key":"10.1016\/j.modpat.2026.101080_bib174","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1007\/s00268-018-4551-8","article-title":"Medullary thyroid carcinoma: survival analysis and evaluation of mutation-specific immunohistochemistry in detection of sporadic disease","volume":"42","author":"Jayakody","year":"2018","journal-title":"World J Surg"},{"issue":"5","key":"10.1016\/j.modpat.2026.101080_bib175","first-page":"943","article-title":"Current status of inherited medullary thyroid carcinoma in Japan","volume":"3","author":"Takami","year":"1996","journal-title":"Oncol Rep"},{"issue":"10","key":"10.1016\/j.modpat.2026.101080_bib176","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/S0046-8177(98)90417-8","article-title":"Medullary thyroid carcinoma: search for histological predictors of survival (109 proband cases analysis)","volume":"29","author":"Franc","year":"1998","journal-title":"Hum Pathol"},{"issue":"11","key":"10.1016\/j.modpat.2026.101080_bib177","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1038\/sj.bjc.6601453","article-title":"The Ki-67 index: a prognostic marker in medullary thyroid carcinoma","volume":"89","author":"Tisell","year":"2003","journal-title":"Br J Cancer"},{"issue":"9","key":"10.1016\/j.modpat.2026.101080_bib178","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2023.100235","article-title":"Independent validation of the International Grading System for Medullary Thyroid Carcinoma: a single institution experience","volume":"36","author":"Lubin","year":"2023","journal-title":"Mod Pathol"},{"issue":"11","key":"10.1016\/j.modpat.2026.101080_bib179","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1177\/10507256251388028","article-title":"Validation of the International Medullary Thyroid Carcinoma Grading System in Patients with Distant Metastases","volume":"35","author":"Porcelli","year":"2025","journal-title":"Thyroid"},{"issue":"5","key":"10.1016\/j.modpat.2026.101080_bib180","doi-asserted-by":"crossref","first-page":"737","DOI":"10.3390\/cancers17050737","article-title":"Validation of the International Medullary Thyroid Cancer Grading System and identification of EZH2 as a prognostic and potential therapeutic marker in medullary thyroid cancer","volume":"17","author":"Jager","year":"2025","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.modpat.2026.101080_bib181","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13000-026-01787-7","article-title":"Clinical pathological characteristics and prognostic analysis of 140 cases of medullary thyroid carcinoma: validation of the international medullary thyroid carcinoma grading system in a Chinese cohort","volume":"21","author":"Zhang","year":"2026","journal-title":"Diagn Pathol"},{"issue":"4","key":"10.1016\/j.modpat.2026.101080_bib182","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1089\/thy.2024.0444","article-title":"The usefulness of the international grading system in the management of sporadic medullary thyroid carcinoma","volume":"35","author":"Prete","year":"2025","journal-title":"Thyroid"},{"key":"10.1016\/j.modpat.2026.101080_bib183","doi-asserted-by":"crossref","DOI":"10.1016\/j.anndiagpath.2023.152112","article-title":"Grading system for medullary thyroid carcinoma: an institutional experience","volume":"64","author":"Podany","year":"2023","journal-title":"Ann Diagn Pathol"},{"issue":"2","key":"10.1016\/j.modpat.2026.101080_bib184","first-page":"124","article-title":"Predictive testing for multiple endocrine neoplasia type 2A (MEN 2A) based on the detection of mutations in the RET protooncogene","volume":"116","author":"Chi","year":"1994","journal-title":"Surgery"},{"key":"10.1016\/j.modpat.2026.101080_bib185","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2026.1794118","article-title":"Precision management of medullary thyroid carcinoma: a dynamic framework integrating biomarkers, genotyping, and risk stratification","volume":"17","author":"Jia","year":"2026","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"10.1016\/j.modpat.2026.101080_bib186","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/847603","article-title":"Pediatric ethics guidelines for hereditary medullary thyroid cancer","volume":"2011","author":"Rosenthal","year":"2011","journal-title":"Int J Pediatr Endocrinol"},{"issue":"7","key":"10.1016\/j.modpat.2026.101080_bib187","doi-asserted-by":"crossref","DOI":"10.6004\/jnccn.2025.0033","article-title":"NCCN guidelines\u00ae insights: thyroid carcinoma, version 1.2025: featured updates to the NCCN guidelines\u00ae","volume":"23","author":"Haddad","year":"2025","journal-title":"J Natl Compr Canc Netw"},{"issue":"11","key":"10.1016\/j.modpat.2026.101080_bib188","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.1210\/jc.2017-02529","article-title":"Val804Met, the Most Frequent Pathogenic Mutation in RET, confers a very low lifetime risk of medullary thyroid cancer","volume":"103","author":"Loveday","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.modpat.2026.101080_bib189","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1097\/00000658-199906000-00016","article-title":"Patterns of nodal metastases in palpable medullary thyroid carcinoma","volume":"229","author":"Moley","year":"1999","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.modpat.2026.101080_bib190","first-page":"290","article-title":"[Cervical lymph node metastasis in medullary thyroid carcinoma]","volume":"50","author":"Yan","year":"2015","journal-title":"Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi"},{"key":"10.1016\/j.modpat.2026.101080_bib191","article-title":"Management of lymph nodes in medullary thyroid carcinoma: a review","volume":"81","author":"Shaghaghi","year":"2022","journal-title":"Ann Med Surg (Lond)"},{"issue":"11","key":"10.1016\/j.modpat.2026.101080_bib192","doi-asserted-by":"crossref","first-page":"6572","DOI":"10.1245\/s10434-021-09683-8","article-title":"Prophylactic lateral neck dissection for medullary thyroid carcinoma is not associated with improved survival","volume":"28","author":"Spanheimer","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.modpat.2026.101080_bib193","doi-asserted-by":"crossref","first-page":"609","DOI":"10.3390\/medicina57060609","article-title":"A review of the significance in measuring preoperative and postoperative carcinoembryonic antigen (CEA) values in patients with medullary thyroid carcinoma (MTC)","volume":"57","author":"Passos","year":"2021","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.modpat.2026.101080_bib194","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.749973","article-title":"Prognostic value of preoperative serum calcitonin levels for predicting the recurrence of medullary thyroid carcinoma","volume":"12","author":"Park","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.modpat.2026.101080_bib195","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/1893047","article-title":"Medullary thyroid carcinoma: an update on imaging","volume":"2019","author":"Kushchayev","year":"2019","journal-title":"J Thyroid Res"},{"issue":"15","key":"10.1016\/j.modpat.2026.101080_bib196","doi-asserted-by":"crossref","first-page":"3643","DOI":"10.3390\/cancers14153643","article-title":"Update on the diagnosis and management of medullary thyroid cancer: what has changed in recent years?","volume":"14","author":"Kaliszewski","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"3","key":"10.1016\/j.modpat.2026.101080_bib197","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s12020-018-1706-1","article-title":"SSTR2A expression in medullary thyroid carcinoma is correlated with longer survival","volume":"62","author":"de Vries","year":"2018","journal-title":"Endocrine"},{"issue":"1","key":"10.1016\/j.modpat.2026.101080_bib198","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s12020-022-03116-6","article-title":"Somatostatin receptor-directed molecular imaging for therapeutic decision-making in patients with medullary thyroid carcinoma","volume":"78","author":"Serfling","year":"2022","journal-title":"Endocrine"},{"issue":"3","key":"10.1016\/j.modpat.2026.101080_bib199","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.eprac.2023.12.008","article-title":"The clinical utility of gallium-68-DOTATATE positron emission tomography scanning in medullary thyroid cancer","volume":"30","author":"Gild","year":"2024","journal-title":"Endocr Pract"},{"issue":"1","key":"10.1016\/j.modpat.2026.101080_bib200","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13044-026-00290-x","article-title":"Safety and efficacy of peptide receptor radionuclide therapy for advanced medullary thyroid cancer: a systematic review and meta-analysis","volume":"19","author":"Abdlkadir","year":"2026","journal-title":"Thyroid Res"},{"key":"10.1016\/j.modpat.2026.101080_bib201","article-title":"Management of medullary thyroid cancer based on variation of carcinoembryonic antigen and calcitonin","volume":"15","author":"Wang","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"10.1016\/j.modpat.2026.101080_bib202","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1046\/j.1365-2265.1998.00392.x","article-title":"Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients. The GETC study group. Groupe d\u2019\u00e9tude des tumeurs \u00e0 calcitonine","volume":"48","author":"Modigliani","year":"1998","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"10.1016\/j.modpat.2026.101080_bib203","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/cen.12852","article-title":"Postoperative biochemical remission of serum calcitonin is the best predictive factor for recurrence-free survival of medullary thyroid cancer: a large-scale retrospective analysis over 30 years","volume":"84","author":"Jung","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"10.1016\/j.modpat.2026.101080_bib204","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1530\/EJE-07-0667","article-title":"Progression of medullary thyroid carcinoma: assessment with calcitonin and carcinoembryonic antigen doubling times","volume":"158","author":"Giraudet","year":"2008","journal-title":"Eur J Endocrinol"},{"issue":"11","key":"10.1016\/j.modpat.2026.101080_bib205","doi-asserted-by":"crossref","first-page":"6077","DOI":"10.1210\/jc.2005-0044","article-title":"Prognostic impact of serum calcitonin and carcinoembryonic antigen doubling times in patients with medullary thyroid carcinoma","volume":"90","author":"Barbet","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.modpat.2026.101080_bib206","first-page":"1193","article-title":"Tumor grade predicts for calcitonin doubling times and disease-specific outcomes after resection of medullary thyroid carcinoma","volume":"32","author":"Nigam","year":"2022","journal-title":"Thyroid"},{"issue":"12","key":"10.1016\/j.modpat.2026.101080_bib207","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1093\/annonc\/mdz400","article-title":"Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment, and follow-up","volume":"30","author":"Filetti","year":"2019","journal-title":"Ann Oncol"},{"issue":"3","key":"10.1016\/j.modpat.2026.101080_bib208","doi-asserted-by":"crossref","first-page":"514","DOI":"10.3803\/EnM.2021.1082","article-title":"Current guidelines for management of medullary thyroid carcinoma","volume":"36","author":"Kim","year":"2021","journal-title":"Endocrinol Metab"},{"issue":"19","key":"10.1016\/j.modpat.2026.101080_bib209","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.3390\/cancers17193193","article-title":"Predictors of distant metastasis in patients with medullary thyroid carcinoma","volume":"17","author":"Ros-Madrid","year":"2025","journal-title":"Cancers (Basel)"},{"issue":"Suppl 1","key":"10.1016\/j.modpat.2026.101080_bib210","article-title":"Treatment of advanced medullary thyroid cancer","volume":"6","author":"Smit","year":"2013","journal-title":"Thyroid Res"},{"issue":"6","key":"10.1016\/j.modpat.2026.101080_bib211","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1210\/jc.2010-0800","article-title":"Harvesting the low-hanging fruit: kinase inhibitors for therapy of advanced medullary and nonmedullary thyroid cancer","volume":"95","author":"Fagin","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.modpat.2026.101080_bib212","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.bcp.2010.05.003","article-title":"Targeted therapy of thyroid cancer","volume":"80","author":"Sherman","year":"2010","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"10.1016\/j.modpat.2026.101080_bib213","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1200\/JCO.2011.37.8638","article-title":"Progress in molecular targeted therapy for thyroid cancer: vandetanib in medullary thyroid cancer","volume":"30","author":"Solomon","year":"2012","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.modpat.2026.101080_bib214","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1200\/JCO.2011.35.5040","article-title":"Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double-blind phase III trial","volume":"30","author":"Wells","year":"2012","journal-title":"J Clin Oncol"},{"issue":"29","key":"10.1016\/j.modpat.2026.101080_bib215","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.1200\/JCO.2012.48.4659","article-title":"Cabozantinib in progressive medullary thyroid cancer","volume":"31","author":"Elisei","year":"2013","journal-title":"J Clin Oncol"},{"issue":"11","key":"10.1016\/j.modpat.2026.101080_bib216","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1093\/annonc\/mdx479","article-title":"Overall survival analysis of EXAM, a phase III trial of cabozantinib in patients with radiographically progressive medullary thyroid carcinoma","volume":"28","author":"Schlumberger","year":"2017","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.modpat.2026.101080_bib217","first-page":"47","article-title":"Cabozantinib for the treatment of metastatic medullary thyroid carcinoma","volume":"5","author":"Nix","year":"2014","journal-title":"J Adv Pract Oncol"},{"key":"10.1016\/j.modpat.2026.101080_bib218","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ctrv.2018.04.007","article-title":"Management of treatment-related toxicities in advanced medullary thyroid cancer","volume":"66","author":"Brose","year":"2018","journal-title":"Cancer Treat Rev"},{"issue":"10","key":"10.1016\/j.modpat.2026.101080_bib219","doi-asserted-by":"crossref","first-page":"3258","DOI":"10.3390\/ijms19103258","article-title":"Pazopanib, cabozantinib, and vandetanib in the treatment of progressive medullary thyroid cancer with a special focus on the adverse effects on hypertension","volume":"19","author":"Milling","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.modpat.2026.101080_bib220","doi-asserted-by":"crossref","first-page":"7893","DOI":"10.2147\/CMAR.S127848","article-title":"Evaluating vandetanib in the treatment of medullary thyroid cancer: patient-reported outcomes","volume":"11","author":"Fallahi","year":"2019","journal-title":"Cancer Manag Res"},{"issue":"1","key":"10.1016\/j.modpat.2026.101080_bib221","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1089\/thy.2024.0495","article-title":"Efficacy and safety of selective RET inhibitors in patients with advanced hereditary medullary thyroid carcinoma","volume":"35","author":"Hamidi","year":"2025","journal-title":"Thyroid"},{"issue":"8","key":"10.1016\/j.modpat.2026.101080_bib222","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S2213-8587(21)00120-0","article-title":"Pralsetinib for patients with advanced or metastatic RET-altered thyroid cancer (ARROW): a multicohort, open-label, registrational, phase 1\/2 study","volume":"9","author":"Subbiah","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"9","key":"10.1016\/j.modpat.2026.101080_bib223","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1056\/NEJMoa2005651","article-title":"Efficacy of selpercatinib in RET-altered thyroid cancers","volume":"383","author":"Wirth","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.modpat.2026.101080_bib224","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2025.1683624","article-title":"Review and analysis of clinical trials of selective RET inhibitors for the treatment of thyroid cancer","volume":"15","author":"Zhou","year":"2025","journal-title":"Front Oncol"},{"key":"10.1016\/j.modpat.2026.101080_bib225","doi-asserted-by":"crossref","DOI":"10.1177\/17588359221101691","article-title":"RET kinase inhibitors for RET-altered thyroid cancers","volume":"14","author":"Vodopivec","year":"2022","journal-title":"Ther Adv Med Oncol"},{"issue":"18","key":"10.1016\/j.modpat.2026.101080_bib226","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1158\/1078-0432.CCR-23-0459","article-title":"FDA approval summary: selpercatinib for the treatment of advanced RET fusion-positive solid tumors","volume":"29","author":"Duke","year":"2023","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.modpat.2026.101080_bib227","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2026.108237","article-title":"FDA-approved RET protein-tyrosine kinase inhibitors in the management of RET-driven thyroid and lung cancer","volume":"229","author":"Roskoski","year":"2026","journal-title":"Pharmacol Res"},{"issue":"4","key":"10.1016\/j.modpat.2026.101080_bib229","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jtho.2020.01.006","article-title":"RET solvent front mutations mediate acquired resistance to selective RET inhibition in RET-driven malignancies","volume":"15","author":"Solomon","year":"2020","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.modpat.2026.101080_bib230","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.864253","article-title":"Sporadic medullary thyroid carcinoma: toward a precision medicine","volume":"13","author":"Matrone","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"10.1016\/j.modpat.2026.101080_bib231","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1186\/s12964-024-01837-x","article-title":"Molecular genetics, therapeutics and RET inhibitor resistance for medullary thyroid carcinoma and future perspectives","volume":"22","author":"Zhang","year":"2024","journal-title":"Cell Commun Signal"},{"issue":"7","key":"10.1016\/j.modpat.2026.101080_bib232","doi-asserted-by":"crossref","first-page":"R85","DOI":"10.1530\/ERC-21-0368","article-title":"Metastatic medullary thyroid carcinoma: a new way forward","volume":"29","author":"Angelousi","year":"2022","journal-title":"Endocr Relat Cancer"},{"issue":"5","key":"10.1016\/j.modpat.2026.101080_bib233","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1210\/endrev\/bnad013","article-title":"Medullary thyroid cancer: updates and challenges","volume":"44","author":"Gild","year":"2023","journal-title":"Endocr Rev"},{"issue":"3","key":"10.1016\/j.modpat.2026.101080_bib234","doi-asserted-by":"crossref","first-page":"710","DOI":"10.3390\/cancers15030710","article-title":"MAPK pathway inhibitors in thyroid cancer: preclinical and clinical data","volume":"15","author":"Schubert","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.modpat.2026.101080_bib235","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3389\/fonc.2017.00238","article-title":"Targeted therapy for medullary thyroid cancer: a review","volume":"7","author":"Priya","year":"2017","journal-title":"Front Oncol"},{"issue":"7","key":"10.1016\/j.modpat.2026.101080_bib236","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.3390\/ijms23073470","article-title":"State of the Art in the current management and future directions of targeted therapy for differentiated thyroid cancer","volume":"23","author":"Silaghi","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.modpat.2026.101080_bib237","doi-asserted-by":"crossref","DOI":"10.1200\/OA-25-00116","article-title":"Preliminary safety and efficacy of tarlatamab in medullary thyroid carcinoma","volume":"3","author":"Roberts","year":"2026","journal-title":"JCO Oncol Adv"},{"issue":"9","key":"10.1016\/j.modpat.2026.101080_bib238","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1097\/PAS.0000000000002571","article-title":"DLL3 Expression in a genotyped cohort of sporadic medullary thyroid carcinomas","volume":"50","author":"Riascos","year":"2026","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.modpat.2026.101080_bib239","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s12022-025-09894-9","article-title":"Multi-center assessment of DLL3 expression by immunohistochemistry in medullary thyroid carcinoma","volume":"36","author":"Ruz-Caracuel","year":"2025","journal-title":"Endocr Pathol"},{"issue":"3","key":"10.1016\/j.modpat.2026.101080_bib240","doi-asserted-by":"crossref","first-page":"36","DOI":"10.21037\/cco-23-133","article-title":"Immunotherapy for patients with thyroid cancer: a comprehensive appraisal","volume":"13","author":"Pinheiro Neto","year":"2024","journal-title":"Chin Clin Oncol"},{"issue":"3","key":"10.1016\/j.modpat.2026.101080_bib241","doi-asserted-by":"crossref","DOI":"10.1002\/edm2.241","article-title":"Expression of PD-L1 in medullary thyroid carcinoma\u2014a new therapeutic target?","volume":"4","author":"Fonseca","year":"2021","journal-title":"Endocrinol Diabetes Metab"},{"issue":"9","key":"10.1016\/j.modpat.2026.101080_bib242","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1089\/thy.2019.0604","article-title":"Comprehensive immune profiling of medullary thyroid cancer","volume":"30","author":"Pozdeyev","year":"2020","journal-title":"Thyroid"},{"issue":"1","key":"10.1016\/j.modpat.2026.101080_bib243","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/s41467-025-67533-7","article-title":"Multi-center multi-omics integration predicts individualized prognosis in medullary thyroid carcinoma","volume":"17","author":"Zhou","year":"2026","journal-title":"Nat Commun"},{"key":"10.1016\/j.modpat.2026.101080_bib244","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmpb.2025.109207","article-title":"A novel multimodal diagnostic framework integrating hyperspectral imaging and deep learning for predicting RET gene mutations in medullary thyroid carcinoma","volume":"275","author":"Yang","year":"2026","journal-title":"Comput Methods Programs Biomed"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395226001237?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395226001237?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T14:45:14Z","timestamp":1792075514000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395226001237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":243,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0893395226001237"],"URL":"https:\/\/doi.org\/10.1016\/j.modpat.2026.101080","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"C-Cell Lesions and Medullary Thyroid Carcinoma: A Review","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.modpat.2026.101080","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 THE AUTHORS. Published by Elsevier Inc. on behalf of the United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}],"article-number":"101080"}}